MAI Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.86M Buy
38,371
+186
+0.5% +$28.5K 0.03% 374
2025
Q4
$5.26M Buy
38,185
+8,397
+28% +$1.1M 0.03% 385
2025
Q3
$3.82M Buy
29,788
+5,295
+22% +$646K 0.02% 421
2025
Q2
$2.96M Buy
24,493
+2,025
+9% +$228K 0.02% 421
2025
Q1
$2.5M Sell
22,468
-1,593
-7% -$170K 0.02% 443
2024
Q4
$2.34M Buy
24,061
+6,472
+37% +$690K 0.02% 454
2024
Q3
$2.02M Sell
17,589
-19,168
-52% -$2.17M 0.02% 398
2024
Q2
$3.91M Buy
36,757
+3,867
+12% +$388K 0.04% 295
2024
Q1
$3.18M Buy
32,890
+7,426
+29% +$761K 0.03% 317
2023
Q4
$2.57M Buy
25,464
+2,053
+9% +$198K 0.03% 278
2023
Q3
$2.38M Sell
23,411
-266
-1% -$27K 0.04% 275
2023
Q2
$2.39M Buy
23,677
+8,114
+52% +$812K 0.04% 270
2023
Q1
$1.43M Buy
15,563
+445
+3% +$38.9K 0.02% 353
2022
Q4
$1.37M Buy
15,118
+3,348
+28% +$282K 0.02% 352
2022
Q3
$895K Buy
11,770
+3,487
+42% +$289K 0.02% 399
2022
Q2
$700K Buy
8,283
+755
+10% +$66.2K 0.01% 463
2022
Q1
$661K Buy
7,528
+1,023
+16% +$88.6K 0.01% 483
2021
Q4
$569K Sell
6,505
-7,788
-54% -$647K 0.01% 534
2021
Q3
$1.17M Buy
14,293
+113
+0.8% +$10.2K 0.02% 345
2021
Q2
$1.29M Buy
14,180
+544
+4% +$48.4K 0.03% 308
2021
Q1
$1.17M Buy
13,636
+1,712
+14% +$154K 0.03% 314
2020
Q4
$1.13M Buy
11,924
+321
+3% +$28.1K 0.03% 298
2020
Q3
$1.01M Sell
11,603
-647
-5% -$56.1K 0.03% 279
2020
Q2
$1.07M Sell
12,250
-393
-3% -$33.9K 0.03% 268
2020
Q1
$1.04M Buy
12,643
+53
+0.4% +$4.73K 0.04% 232
2019
Q4
$1.19M Buy
12,590
+8,643
+219% +$776K 0.04% 250
2019
Q3
$343K Sell
3,947
-1,106
-22% -$99.3K 0.02% 400
2019
Q2
$461K Sell
5,053
-745
-13% -$63.1K 0.02% 363
2019
Q1
$499K Sell
5,798
-339
-6% -$27.2K 0.03% 295
2018
Q4
$472K Buy
+6,137
New +$478K 0.03% 298
2015
Q2
Sell
-2,775
Closed -$245K 491
2015
Q1
$245K Sell
2,775
-201
-7% -$17.8K 0.02% 423
2014
Q4
$247K Buy
+2,976
New +$247K 0.02% 400
2013
Q4
Sell
-3,109
Closed -$214K 397
2013
Q3
$214K Buy
+3,109
New +$206K 0.03% 307

Other funds holding NVS